Subclasses of LpA-I in coronary artery disease: Distribution and cholesterol efflux ability

European Journal of Clinical Investigation

Volumn 27, Issue 4, 1997, Pages 299-307

  Decossin, C ^a   Castro, G ^a   Derudas, B ^a   Bertrand, M ^b   Fruchart, J C ^a   Fievet C ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cholesterol efflux; Coronary artery disease; Electrophoresis; Gel chromatography; LpA I subfractions

Indexed keywords

CHOLESTEROL; LIPOPROTEIN A;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ELECTROPHORESIS; GEL CHROMATOGRAPHY; HUMAN; MALE; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

EID: 0030933058     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1020654.x     Document Type: Article

References (39)

1. Gordon DJ, Rifkind BM. High-density lipoprotein. The clinical implications of recent studies. N Engl J Med 1989;321:1311-16.
2. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of lipids, apolipoproteins and risk of myocardial infarction. N Engl J Med 1991;325:373-81.
3. Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedwald W. Fifteen year mortality in coronary drug project patients: long-term benefit with niacin. J Am Coll Cardiol 1986; 8:1245-55.
4. Blankenhom DH, Alaupovic P, Wickham E, Chin HP, Azen SP. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 1990;81:470-6.
5. Glomset JA. The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
6. Fruchart JC, Ailhaud G. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clin Chem 1992;38:793-7.
7. Cheung MC, Albers JJ. Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II. J Lipid Res 1982; 23:747-53.
8. Atmeh RF, Shepherd J, Packard CJ. Subpopulations of apolipoprotein A-I in human high density lipoproteins: their metabolic properties and response to drug therapy. Biochim Biophys Acta 1983; 751:175-88.
9. Cheung MC, Albers JJ. Characterization of lipoprotein particles isolated by immunoaffinity chromatography. J Biol Chem 1984; 259:12201-9.
10. Puchois P, Kandoussi A, Fiévet P, Fourrier JL, Bertrand M, Koren E, Fruchart JC. Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 1987;68:35-40.
11. Parra HJ, Arveiler D, Evans AE et al. A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The Ectim study. Arterioscler Thromb 1992;12:701-7.
12. Amouyel P, Isorez D, Bard JM, Goldman M, Lebel P, Zylberberg G, Fruchart JC. Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescents. Arterioscler Thromb 1993;13:1640-4.
13. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991;353:265-7.
14. Schultz, JR, Verstuyft JG, Gong EL, Nichols AV, Rubin EM. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature 1993;365:762-4.
15. Ohta T, Hattori S, Nishiyama S, Matsuda I. Studies on the lipid and apolipoprotein compositions of two species of apoA-I containing lipoproteins in normolipidemic males and females. J Lipid Res 1988;29:721-8.
16. Cheung MC, Wolf AC. In vitro transformation of A-I containing lipoprotein subpopulations: role of lecithin cholesterol acyltransferase and B-containing lipoproteins. J Lipid Res 1989;30:499-509.
17. Duverger N, Rader D, Duchateau P, Fruchart JC, Castro G, Brewer HB Jr. Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma. Biochemistry 1993;32:12372-9.
18. Cheung MC, Brown BG, Wolf AC, Albers JJ. Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 1991;32:383-94.
19. Ohta T, Nakamura R, Ikeda Y, Shinohara M, Miyazaki A, Horiuchi S, Matsuda I. Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin cholesterol acyltransferase. Biochim Biophys Acta 1992; 1165:119-28.
20. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC. Differential electroimmunoassay of human LpAI lipoprotein particles on ready-to-use plates. Clin Chem 1990;36:1431-5.
22. Barbaras R, Puchois P, Fruchart JC, Ailhaud G. Cholesterol efflux from adipose cells is mediated by LpAI particles but not by LpA-I/ A-II particles. Biochem Biophys Res Commun 1987;142:63-9.
23. Havel RJ, Eder WA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-53.
24. Lowry OH, Rosebrough NG, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
25. de la Llera Moya M, Atger V, Paul JL et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification and transfer. Arterioscler Thromb 1994;14:1056-65.
26. Patsch W, Schonfeld G, Gotto AM, Patsch JR. Characterization of human high density lipoproteins by zonal ultracentrifugation. J Biol Chem 1980;255:3178-85.
27. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of serum lipoproteins. In: Nelson G, ed. Blood lipids and lipoproteins. New York: Wiley Interscience 1972:181-274.
28. 3 lipid levels in coronary artery disease. Atherosclerosis 1985;59:131-6.
29. Oram JF. Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis 1983;3:420-32.
30. Nowicka G, Brüning T, Böttcher A, Kahl G, Schmitz G. The macrophage interaction of HDL subclasses separated by free flow isotachophoresis. J Lipid Res 1990;31:1947-63.
31. Blanche PJ, Gong EL, Forte TM, Nichols AV. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 1981;665:408-19.
32. Johansson J, Carlson LA, Landou C, Hamsten A. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 1991;11:174-82.
33. Vézina CA, Milne RW, Weech PK, Marcel YL. Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis. J Lipid Res 1988;29:573-85.
34. Li Z, McNamara JR, Ordovas JM, Schaefer EJ. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method. J Lipid Res 1994;35:1698-711.
35. Rader DJ, Castro G, Zech LA, Fruchart J-C, Brewer HB Jr. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I/A-II. J Lipid Res 1991;32:1849-59.
36. Castro G, Fielding CJ. Early incorporation of cell-derived cholesterol into preβ-migrating high density lipoprotein. Biochemistry 1988;27:25-9.
37. Saku K, Liu R, Ohta T, Jimi S, Matsuda I, Arakawa K. Plasma HDL levels are regulated by the catabolic rate of large particles of lipoprotein containing Apo AI. Biochem Biophys Res Commun 1994;200:557-61.
38. Fielding CJ. Reverse cholesterol transport. Curr Opin Lipidol 1991;2:376-8.
39. Forte TM, McCall MR. The role of apolipoprotein A-I containing lipoproteins in atherosclerosis. Curr Opin Lipidol 1994;5: 354-64.